PCVX
Vaxcyte, Inc.Company with tickers: PCVX
CIK
1649094
CUSIP
92243G108
Shares Outstanding
144,397,682
13F Activity (30d)
298 filings
296 filers
Price
$47.86
Market Cap
$6.83B
P/E Ratio
-11.56
EPS (Diluted)
$-4.14
52W High
$65.00
52W Low
$29.08
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $180,793,000 | USD | 2025-03-31 | 10-Q | 2026-05-06 |
| Research & Development | $148,134,000 | USD | 2025-03-31 | 10-Q | 2026-05-06 |
| Operating Income | $-180,793,000 | USD | 2025-03-31 | 10-Q | 2026-05-06 |
| Net Income | $-140,718,000 | USD | 2025-03-31 | 10-Q | 2026-05-06 |
| EPS (Basic) | $-1.04 | USD/shares | 2025-03-31 | 10-Q | 2026-05-06 |
| EPS (Diluted) | $-1.04 | USD/shares | 2025-03-31 | 10-Q | 2026-05-06 |